858 Therapeutics News and Activities

Acquisition, funding and merger involving 858 Therapeutics.

• 858 Therapeutics has just announced a $50 Million fundraising (posted on September 27 2024).

View the org chart displaying its 10 main executives

Most searched biographies at 858 Therapeutics

• Jeffrey Stafford, Chief Executive Officer
• Hailey Spencer, Director
• Clare Ozawa, Director

Create your alert
to follow the executive moves at 858 Therapeutics.

858 Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by 858 Therapeutics

• 8five8 Therapeutics | News & Publications
• 858 Therapeutics Announces Initial Data from First-in-Human Phase 1/2 Trial of PARG Inhibitor ETX-19477 to be Presented at 2026 ASCO Annual Meeting
• 858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, Platinum-Resistant Ovarian Cancer
• 858 Therapeutics and OpenBench Launch Small Molecule Drug Discovery Collaboration
• 858 Therapeutics Announces $50 Million Series B Financing
• 858 Therapeutics Expands Leadership Team to Support Transition to the Clinic
• 858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting
• 858 Therapeutics Expands Board of Directors and Leadership Team
• 858 Therapeutics Launches with Proven Team and $60 Million Series A Financing | Business Wire
• View more press releases Close

Social media about 858 Therapeutics

• 858 Therapeutics on Wikipedia, Google News & Yahoo Finance
• 858 Therapeutics on LinkedIn, X (Twitter) & YouTube